Acetamide

Endpoint summary

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Reference

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: Data obtained from a guideline study according to OECD Guideline 429 and therefore considered reliable without restrictions.

Qualifier:

according to guideline

Guideline:

OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Type of study:

mouse local lymph node assay (LLNA)

Species:

mouse

Strain:

CBA

Sex:

female

Details on test animals and environmental conditions:

Test system: Mice, CBA/CaOlaHsd
Rationale: Recognised as the recommended test system.
Source: Harlan Laboratories B.V.Postbus 6174,5960 AD Horst / The Netherlands
Number of animals for the pre-test: 2 females
Number of animals for the main study: 16 females
Number of animals per group: 4 females (nulliparous and non-pregnant)
Number of test groups: 3
Number of control (vehicle) groups: 1
Age: Pre-test: 9 - 10 weeks (beginning of treatment)
Main study: 9 - 11 weeks (beginning of treatment)
Acclimation: At least 5 days prior to the start of dosing under test conditions after health examination. Only animals without any visible signs of illness were used for the study.
Housing: group
Cage Type: Makrolon Type II (pre-test) / III (main study), with wire mesh top
Bedding: granulated soft wood bedding
Feed: 2018C Teklad Global 18% protein rodent diet
(certified), ad libitum
Water: tap water, ad libitum
Environment: temperature 22 + 2°C
relative humidity approx. 45-65%, except for few hours on
one day (see deviation)
artificial light 6.00 a.m. - 6.00 p.m.

Vehicle:

other: Ethanol/water (7+3, v/v)

Concentration:

The test item in the main study was assayed at 10, 25, and 50% (w/v). The highest concentration tested was the highest level that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation as confirmed in the pre-experiment.

No. of animals per dose:

Number of animals per group: 4 females (nulliparous and non-pregnant)
Number of test groups: 3
Number of control (vehicle) groups: 1

Positive control substance(s):

hexyl cinnamic aldehyde (CAS No 101-86-0)

Test item concentration %	Group	Measurement DPM	Calculation			Result
			DPM-BG^a)	number of lymph nodes	DPM per lymph node^b)	S.I.
---	BG I	15	---	---	---	---
---	BG II	57	---	---	---	---
0	1	3260	3224.0	8	403.0	1.00
10	2	3041	3005.0	8	375.6	0.93
25	3	3996	3960.0	8	495.0	1.23
50	4	3502	3466.0	8	433.3	1.08

1    =  Control Group

2-4=  Test Group

^a)   =  The mean value was taken from the figures BG I and BG II

^b)    =  Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled

The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.

Interpretation of results:

not sensitising

Remarks:

Migrated information Criteria used for interpretation of results: EU

Conclusions:

In the study the test item Acetamid formulated in ethanol/water (7+3, v/v) was assessed for its possible skin sensitising potential following OECD Guideline 429.
For this purpose a local lymph node assay was performed using test item concentrations of 10, 25, and 50% (w/v).
The animals did not show any signs of systemic toxicity or local skin irritation during the course of the study and no cases of mortality were observed.
In this study Stimulation Indices (S.I.) of 0.93, 1.23, and 1.08 were determined with the test item at concentrations of 10, 25, and 50% (w/v) in ethanol/water (7+3, v/v), respectively.
The test item Acetamid was not a skin sensitiser under the test conditions of this study.

Executive summary:

In order to study a possible skin sensitising potential of Acetamid, three groups each of four female mice were treated once daily with the test item at concentrations of 10, 25, and 50% (w/v) in ethanol/water (7+3, v/v) by topical application to the dorsum of each ear for three consecutive days. A control group of four mice was treated with the vehicle (ethanol/water (7+3, v/v)) only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (³H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of³H‑methyl thymidine measured in ab-scintillation counter.

All treated animals survived the scheduled study period and no signs of systemic toxicity or local skin irritation were observed.

A test item is regarded as a sensitiser in the LLNA if the exposure to one or more test concentration resulted in a 3-fold or greater increase in incorporation of³HTdR compared with concurrent controls, as indicated by the Stimulation Index (S.I.). The estimated concentration of test item required to produce a S.I. of 3 is referred to as the EC3 value.

In this study Stimulation Indices of 0.93, 1.23, and 1.08 were determined with the test item at concentrations of 10, 25, and 50% (w/v) in ethanol/water (7+3, v/v). A dose response was not observed. The EC3 value could not be calculated, since none of the tested concentrations induced a S.I. greater than the threshold value of 3. The test item Acetamid was not a skin sensitiser under the test conditions of this study.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (not sensitising)

Additional information:

In the study the test item Acetamid formulated in ethanol/water (7+3, v/v) was assessed for its possible skin sensitising potential following OECD Guideline 429. For this purpose a local lymph node assay was performed using test item concentrations of 10, 25, and 50% (w/v). The animals did not show any signs of systemic toxicity or local skin irritation during the course of the study and no cases of mortality were observed. In this study Stimulation Indices (S.I.) of 0.93, 1.23, and 1.08 were determined with the test item at concentrations of 10, 25, and 50% (w/v) in ethanol/water (7+3, v/v), respectively. The test item Acetamid was not a skin sensitiser under the test conditions of this study.

Migrated from Short description of key information:
Acetamide was found to be not a skin sensitizer in a LLNA-study according to OECD Guideline 429.

Justification for selection of skin sensitisation endpoint:
Data obtained from a GLP compliant study according to OECD Guideline 429.

Justification for classification or non-classification

In the LLNA study Stimulation Indices of 0.93, 1.23, and 1.08 were determined with the test item at concentrations of 10, 25, and 50% (w/v) in ethanol/water (7+3, v/v). A dose response was not observed. The EC3 value could not be calculated, since none of the tested concentrations induced a S.I. greater than the threshold value of 3.

In conclusion, under the present test conditions, Acetamide did not reveal any sensitising properties in the local lymph node assay. Thus, the classification criteria acc. Directive 67/548/EEC and regulation (EC) No. 1272/2008 as skin sensitizer are not met. No classification is required.